Analysis of the bone marrow, showed a 2.56-times higher median cellularity in the Srb1-treated group, with a median of tumor cells 1,761-fold lower than in isotype control treated animals (p=0.00001) (Figure 5D, Table 2). The gene discussed is SCARB1; the disease is neoplasm.